HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Apparent noncompetitive antagonism of muscarinic receptor mediated Ca2+ mobilization by some muscarinic antagonists.

Abstract
Ca2+ mobilizations in SH-SY5Y and IMR-32 human neuroblastoma cell lines were measured using the fluorescent Ca2+ indicator fura-2. A variety of antagonists (atropine, pirenzepine, 4-DAMP and N-methyl-scopolamine) inhibited carbamyl choline-induced transient Ca2+ mobilization both in a competitive and a noncompetitive manner. The apparent noncompetitive inhibition constants were lower in IMR-32 than in SH-SY5Y cells even when the competitive inhibition constants were similar. This may relate to the previously reported differential expression of muscarinic receptor subtypes in these cell lines.
AuthorsJ Kukkonen, K E Akerman
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 189 Issue 2 Pg. 919-24 (Dec 15 1992) ISSN: 0006-291X [Print] United States
PMID1472064 (Publication Type: Journal Article)
Chemical References
  • Muscarinic Antagonists
  • Parasympatholytics
  • Piperidines
  • Receptors, Muscarinic
  • Scopolamine Derivatives
  • Pirenzepine
  • Atropine
  • 4-diphenylacetoxy-1,1-dimethylpiperidinium
  • Calcium
  • Fura-2
  • N-Methylscopolamine
Topics
  • Atropine (pharmacology)
  • Calcium (metabolism)
  • Fura-2
  • Humans
  • Kinetics
  • Muscarinic Antagonists
  • N-Methylscopolamine
  • Neuroblastoma
  • Parasympatholytics (pharmacology)
  • Piperidines (pharmacology)
  • Pirenzepine (pharmacology)
  • Receptors, Muscarinic (drug effects, physiology)
  • Scopolamine Derivatives (metabolism, pharmacology)
  • Spectrometry, Fluorescence
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: